tiprankstipranks
Immunome (IMNM)
NASDAQ:IMNM
US Market
Holding IMNM?
Track your performance easily

Immunome (IMNM) Financial Statements

194 Followers

Immunome Financial Overview

Immunome's market cap is currently ―. The company's EPS TTM is $-8.117; its P/E ratio is -1.15; Immunome is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.66. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 2.91M$ 2.36M$ 1.03M$ 3.83M$ 3.56M
Gross Profit$ 2.91M$ 2.36M$ 1.03M$ 3.83M$ 3.56M
EBIT$ -50.52M$ -40.01M$ -20.34M$ -94.65M$ -4.63M
EBITDA$ -49.95M$ -38.80M$ -20.08M$ -94.35M$ -4.47M
Net Income Common Stockholders$ -47.10M$ -36.12M$ -129.49M$ -92.63M$ -4.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 240.20M$ 278.30M$ 309.70M$ 138.14M$ 90.64M
Total Assets$ 256.90M$ 296.21M$ 319.75M$ 148.54M$ 93.16M
Total Debt$ 2.46M$ 2.48M$ 1.21M$ 0.00$ 0.00
Net Debt$ -237.74M$ -275.82M$ -308.49M$ -138.14M$ -90.64M
Total Liabilities$ 41.99M$ 42.38M$ 34.18M$ 28.66M$ 87.08M
Stockholders Equity$ 214.91M$ 253.84M$ 285.57M$ 119.89M$ 6.08M
Cash Flow-
Free Cash Flow$ -35.71M$ -10.73M$ -28.34M$ -17.81M$ -8.65M
Operating Cash Flow$ -34.17M$ -23.40M$ -11.17M$ -17.46M$ -8.61M
Investing Cash Flow$ 24.10M$ -81.69M$ -37.23M$ -30.00M$ -36.00K
Financing Cash Flow$ 305.00K$ 694.00K$ 219.44M$ 55.50M$ 60.88M
Currency in USD

Immunome Earnings and Revenue History

Immunome Debt to Assets

Immunome Cash Flow

Immunome Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis